Philippe Gaulard

1986–2024 年に発表

187
論文数
37,658
被引用数
107
h 指数
186
i10 指数

被引用数

Philippe Gaulard の年別被引用数1988 年: 被引用 2 件1989 年: 被引用 5 件1990 年: 被引用 6 件1991 年: 被引用 7 件1992 年: 被引用 4 件1993 年: 被引用 10 件1994 年: 被引用 11 件1995 年: 被引用 26 件1996 年: 被引用 28 件1997 年: 被引用 60 件1998 年: 被引用 55 件1999 年: 被引用 45 件2000 年: 被引用 72 件2001 年: 被引用 100 件2002 年: 被引用 115 件2003 年: 被引用 197 件2004 年: 被引用 150 件2005 年: 被引用 197 件2006 年: 被引用 205 件2007 年: 被引用 230 件2008 年: 被引用 279 件2009 年: 被引用 222 件2010 年: 被引用 238 件2011 年: 被引用 275 件2012 年: 被引用 270 件2013 年: 被引用 240 件2014 年: 被引用 263 件2015 年: 被引用 256 件2016 年: 被引用 238 件2017 年: 被引用 275 件2018 年: 被引用 189 件2019 年: 被引用 843 件2020 年: 被引用 821 件2021 年: 被引用 812 件2022 年: 被引用 726 件2023 年: 被引用 553 件2024 年: 被引用 926 件2025 年: 被引用 348 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,509 件、この内訳の 24.1%フランス: 引用元論文 857 件、この内訳の 8.2%ドイツ: 引用元論文 731 件、この内訳の 7%中国: 引用元論文 679 件、この内訳の 6.5%イタリア: 引用元論文 647 件、この内訳の 6.2%イギリス: 引用元論文 614 件、この内訳の 5.9%カナダ: 引用元論文 419 件、この内訳の 4%スペイン: 引用元論文 385 件、この内訳の 3.7%日本: 引用元論文 367 件、この内訳の 3.5%スイス: 引用元論文 344 件、この内訳の 3.3%オランダ: 引用元論文 303 件、この内訳の 2.9%オーストラリア: 引用元論文 219 件、この内訳の 2.1%
0%24.1%その他 22.6%

分野

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology11.4%
  • Immunology and Microbiology8.2%
  • Neuroscience1.3%
  • Computer Science0.3%
  • Pharmacology, Toxicology and Pharmaceutics0.1%
  • その他0.6%

トピック

  • Lymphoma Diagnosis and Treatment19.6%
  • Viral-associated cancers and disorders6.3%
  • Chronic Lymphocytic Leukemia Research5.3%
  • CAR-T cell therapy research5%
  • Immune Cell Function and Interaction4.9%
  • CNS Lymphoma Diagnosis and Treatment4.7%
  • その他54.2%

共著者

全論文

検索で開く
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2002 被引用: 5,562

  3. Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 被引用: 192

  4. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laurence de Leval, Joseph M. Connors, Jamés O. Armitage, Julie M. Vose, Wing C. Chan, Louis M. Staudt - Blood 2014 被引用: 540

  5. Genomic profiling for clinical decision making in lymphoid neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 被引用: 161

  6. Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masao Seto, Andreas Rosenwald, German Ott, Elı́as Campo, Lisa M. Rimsza, Elaine S. Jaffe, Rita M. Braziel, Francesco d’Amore, Giorgio Inghirami, Francesco Bertoni, Laurence de Leval, Philippe Gaulard, Louis M. Staudt, Timothy W. McKeithan, Stefano Pileri, Wing C. Chan, Javeed Iqbal - Blood 2019 被引用: 275

  7. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 被引用: 1,499

  8. Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gaulard, Gilles Salles, Catherine Burton, Daphne de Jong, Laurie H. Sehn, Delphine Maucort‐Boulch - Journal of Clinical Oncology 2019 被引用: 254

  9. Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

    著者: , , , , , , , , , , - Blood 2007 被引用: 204

  10. High total metabolic tumor volume at baseline predicts survival independent of response to therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2020 被引用: 185

  11. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 545

  12. Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

    著者: , , , , , , , , , , , , , , , - Haematologica 2013 被引用: 171

  13. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma

    著者: , , , , , , , , , , , , , - Blood 2012 被引用: 500

  14. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters

    著者: , , , , , , , , , , , , , , - Blood 2012 被引用: 492

  15. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

    著者: , , , , , , , , , , , , , - Blood 2007 被引用: 621

  16. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin

    著者: , , , , , , , , , , , , , , , , , , , , - Haematologica 2017 被引用: 224

  17. Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma

    著者: , , , , , , , , , , , , , - Blood 2018 被引用: 178

  18. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 被引用: 390

  19. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 被引用: 318

  20. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Françoise Berger, Céline Bossard, Flavie Arbion, Isabelle Quintin‐Roué, Jean‐Michel Picquenot, Martine Patey, Blandine Fabre, Henri Sevestre, Cécile Le Naourès, Marie-Pierre Chenard-Neu, Claire Bastien, S. Thiebault, Laurent Martin, Manuela Delage, Thomas Filleron, Gilles Salles, Thierry Jo Molina, Georges Delsol, Pierre Brousset, Philippe Gaulard - Journal of Clinical Oncology 2017 被引用: 217

  21. Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 195

  22. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 被引用: 57

  23. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshiki Akatsuka, Satoru Miyano, Tadashi Yoshino, Philippe Gaulard, Olivier Hermine, Kengo Takeuchi, Koichi Ohshima, Seishi Ogawa - Leukemia 2019 被引用: 148

  24. Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2017 被引用: 128